• Molecular NameCromoglycate
  • SynonymAcide Cromoglicique [INN-French]; Acido Cromoglicico [INN-Spanish]; Acidum Cromoglicicum [INN-Latin]; Cromoglicic Acid; Cromoglycate; Cromoglycic Acid; Cromolyn
  • Weight468.37
  • Drugbank_IDDB01003
  • ACS_NO16110-51-3
  • Show 3D model
  • LogP (experiment)1.92
  • LogP (predicted, AB/LogP v2.0)1.24
  • pkaN/A
  • LogD (pH=7, predicted)-3.76
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-0.56
  • LogSw (predicted, AB/LogsW2.0)0.04
  • Sw (mg/ml) (predicted, ACD/Labs)0.19
  • No.of HBond Donors3
  • No.of HBond Acceptors11
  • No.of Rotatable Bonds8
  • TPSA165.89
  • StatusFDA approved
  • Administrationtopical: oral, nasal spray, inhaled, eye drops
  • PharmacologyA mast cell stabilizer, and is commonly marketed as the sodium salt sodium cromoglicate or cromolyn sodium. This drug prevents the release of inflammatory chemicals such as histamine from mast cells.
  • Absorption_value1.0
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability3.0
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life1.3 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A